Nina Hanke

1.3k citations
40 papers · 1.1k indexed · h-index 20
Topics
Pharmacogenetics and Drug Metabolism (16 papers)Drug Transport and Resistance Mechanisms (8 papers)Hormonal Regulation and Hypertension (6 papers)

In The Last Decade

Nina Hanke

38 papers receiving 1.1k citations

Peers

Nina Hanke
Comparison fields: 5 of 110
  • Pharmacology 308
  • Molecular Biology 299
  • Oncology 193
  • Pediatrics, Perinatology and Child Health 158
  • Psychiatry and Mental health 126
Replace Rhys Whomsley with:
Rhys Whomsley Belgium
Kazutomi Kusano Japan
Ernesto Callegari United States
Dongsheng Ouyang China
Xiaoping Chen China
Achiel Van Peer Belgium
Mitchell D. Green United States
Ajay Madan United States
Bill J. Smith United States
Nina Hanke relative to Rhys Whomsley Belgium Rhys Whomsley's profile →
Citations per field
00.5×2.9×
Rhys Whomsley · 1×
Citations per year

Countries citing papers authored by Nina Hanke

Since Specialization
Citations

This map shows the geographic impact of Nina Hanke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nina Hanke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nina Hanke more than expected).

Fields of papers citing papers by Nina Hanke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nina Hanke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nina Hanke. The network helps show where Nina Hanke may publish in the future.

Co-authorship network of co-authors of Nina Hanke

This figure shows the co-authorship network connecting the top 25 collaborators of Nina Hanke. A scholar is included among the top collaborators of Nina Hanke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nina Hanke. Nina Hanke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 22
2 47
3 14
4 17
5 11
6 35
7 19
8 41
9 19
10 33
11 10
12 32
13 12
14 17
15 7
16 15
17 1
18 6
19 13
20 43

About Nina Hanke

Nina Hanke is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism and Toxicology, having authored 40 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (16 papers), Drug Transport and Resistance Mechanisms (8 papers) and Hormonal Regulation and Hypertension (6 papers). The work is most often cited by research in Pharmacology (308 citations), Psychiatry and Mental health (126 citations) and Pediatrics, Perinatology and Child Health (158 citations). Nina Hanke has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Thorsten Lehr, Rolf W. Hartmann, Gerolf Gros, Sebastian Frechen, Hans‐Peter Kubis, Hannah Britz, Thomas Wendl, Renate Scheibe, Thomas Eißing and Albert Sjoerdsma. Their work appears in journals such as PLoS ONE, Neurology and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026